Q1 2026 Mediwound Ltd Earnings Call Transcript

May 27, 2026 / 12:30 PM GMT

Release Date Price: €12.8 (-8.57%)

Transcript

Key Points

Positve

MediWound Ltd (MDWD) is advancing its ESCAREX program towards commercialization, with strong engagement from strategic collaborators.
The company has expanded its chronic wound collaboration network, including partnerships with major advanced wound care companies.
MediWound Ltd (MDWD) reported a new 10-year BARDA contract valued at up to $197 million, supporting NexoBrid's strategic role in mass casualty burn response.
The company is preparing its expanded NexoBrid manufacturing facility for commercial readiness, with expected completion of modifications in the second half of 2026.
MediWound Ltd (MDWD) reaffirmed its full-year 2026 revenue guidance of $24 million to $26 million, supported by expected government-related development services.

Negative

Revenue for the first quarter of 2026 was $1.5 million, a significant decrease from $4 million in the first quarter of 2025.
The timeline for the ESCAREX Phase 3 value study has shifted by one quarter, with enrollment progressing more gradually than anticipated.
Research and development expenses increased to $5.2 million from $2.9 million in the first quarter of 2025, reflecting continued investment in the ESCAREX study.
The company reported an operating loss of $8 million for the quarter, compared to $5.2 million in the first quarter of 2025.
Net cash used in operating activities was $9.6 million, contributing to a decrease in cash equivalents and deposits from $54 million at year-end 2025 to $45 million as of March 31, 2026.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MDWD.OQ - Mediwound Ltd
Q1 2026 Mediwound Ltd Earnings Call
May 27, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the Meadowoon first quarter 2026 earnings conference call.

All participants will be in listen-only mode.

Should you need assistance please signal a conference specialist by pressing the star key followed by zero.

After today's presentation there will be an opportunity to ask questions.

To ask a question you may press star then one on your telephone keypad and to withdraw your question please press star then two.

Please note today's event is being recorded. I'd now like to turn the conference over to Dan Ferry of LifeSci Advisors. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.